Back to search

Article

Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the EBMT

2023-06-05

Abstract excerpt

<title>Abstract</title><p><bold>Introduction</bold>High-dose myeloablative chemotherapy followed by autologous stem cell transplantation (ASCT) is a valid treatment option for patients with acute myeloid leukemia (AML) in first complete remission (CR1). However, information on specific conditioning regimens is scarce. The ALWP showed improved outcomes with busulfan and high-dose melphalan (BUMEL) conditioning comp...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d29f152-ab50-53cd-bad5-251d5101eb40
DOI
10.21203/rs.3.rs-2980516/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the EBMTDOI 10.21203/rs.3.rs-2980516/v1
Optimizing the Treatment of Acute Promyelocytic Leukemia: A Maintenance-Free Strategy for Complete RemissionSemantic proximity
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.Semantic proximity
Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach.Semantic proximity
Comparative outcomes of myeloablative and reduced‐intensity conditioning allogeneic hematopoietic cell transplantation for therapy‐related acute myeloid leukemia with prior solid tumor: A report from the acute leukemia working party of the European society for blood and bone marrow transplantationSemantic proximity
HLA-mismatched micro-transplantation as post-remission treatment compared to autologous hematopoietic stem cell transplantation or consolidation with single agent cytarabine for favorable or intermediate risk acute myeloid leukemiaSemantic proximity
Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AMLSemantic proximity
Prognostic Factors Impacting Post-Transplant Outcomes in Adult T-cell Acute Lymphoblastic Leukemia: A Registry-Based Study by the EBMT Acute Leukemia Working PartySemantic proximity
Unmanipulated haploidentical hematopoietic stem cell transplantation for mixed phenotype acute leukemia: a single center studySemantic proximity
Smart Conditioning with Venetoclax Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid MalignanciesSemantic proximity
Frontline treatment of AML in adults.Semantic proximity
[Analysis of the clinical characteristics of acute myeloid leukemia related to the treatment of hematological and solid tumors].Semantic proximity
Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT.Semantic proximity
Select a neighboring publication to make it the new centre.